Cargando…

Allelic variability in PSA & AR genes: A novel biomarker on the horizon for carcinoma prostate

Detalles Bibliográficos
Autor principal:	Dogra, P.N.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Medknow Publications & Media Pvt Ltd 2014
Materias:	Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4069726/ https://www.ncbi.nlm.nih.gov/pubmed/24820826

Ejemplares similares

Contribution of allelic variability in prostate specific antigen (PSA) & androgen receptor (AR) genes to serum PSA levels in men with prostate cancer
por: Chavan, Sushant V., et al.
Publicado: (2014)

Prostate biopsy for elevated prostate specific antigen (PSA) – Indian perspective
por: Ragavan, N.
Publicado: (2014)

Policy and System Approach (PSA): A primer
por: Lahariya, Chandrakant
Publicado: (2017)

Clinical utility of the nuclear-localized AR-V7 biomarker for treatment choice in metastatic castration-resistant prostate cancer
por: Vlaeminck-Guillem, Virginie
Publicado: (2020)

Prostate-Specific Antigen (PSA) Screening and New Biomarkers for Prostate Cancer (PCa)
por: Stephan, Carsten, et al.
Publicado: (2014)

Urinary PSA and Serum PSA for Aggressive Prostate Cancer Detection
por: Höti, Naseruddin, et al.
Publicado: (2023)

New Horizons
por: Dogra, Vikram
Publicado: (2011)

Routine PSA Testing: An Analysis of the Controversy Concerning Its Use
por: Hussain, Namath S.
Publicado: (2005)

Fasting times in serum PSA assay
por: Xu, Xiang, et al.
Publicado: (2014)

Association of Polymorphisms in the Prostate-Specific Antigen (PSA) Gene Promoter with Serum PSA Level and PSA Changes after Dutasteride Treatment in Korean Men with Benign Prostatic Hypertrophy
por: Park, Sung Woon, et al.
Publicado: (2010)

Novel candidate alleles associated with gene regulation for Emery–Dreifuss muscular dystrophy
por: Xiong, Hui
Publicado: (2020)

Commentary: Expanding the horizons of red-free examination
por: Soni, Tanvi, et al.
Publicado: (2022)

Commentary: Behçet’s uveitis – Expanding treatment horizons
por: Moreker, Mayur R
Publicado: (2023)

The Biodevelopment of Sexual Orientation: Beyond the Known Horizon
por: Dragan, Wojciech Ł., et al.
Publicado: (2022)

Prostate Cancer Detection and Prognosis: From Prostate Specific Antigen (PSA) to Exosomal Biomarkers
por: Filella, Xavier, et al.
Publicado: (2016)

PGK1-AR axis: Benefits of a novel actor in PCOS pathology
por: Vezza, Teresa, et al.
Publicado: (2020)

PSA and Beyond: The Past, Present, and Future of Investigative Biomarkers for Prostate Cancer
por: Tosoian, Jeffrey, et al.
Publicado: (2010)

Re: Fasting times in serum PSA assay
por: Lau, Cheryl K, et al.
Publicado: (2014)

Novel and Emerging Tools and Technologies in Cardiac Electrophysiology: What’s on the Horizon in 2020?
por: Aryana, Arash
Publicado: (2019)

Ureteral stents are part of an ever-expanding technology horizon
por: Chi, Thomas, et al.
Publicado: (2014)

Digital Mental Health Challenges and the Horizon Ahead for Solutions
por: Balcombe, Luke, et al.
Publicado: (2021)

Down regulation of PSA by C/EBPα is associated with loss of AR expression and inhibition of PSA promoter activity in the LNCaP cell Line
por: Yin, Hong, et al.
Publicado: (2006)

Biomarkers for hepatocellular carcinoma: What’s new on the horizon?
por: Ocker, Matthias
Publicado: (2018)

Regioselectivity of the S(E)Ar-based cyclizations and S(E)Ar-terminated annulations of 3,5-unsubstituted, 4-substituted indoles
por: Das, Jonali, et al.
Publicado: (2022)

Fungal Diseases in the 21st Century: The Near and Far Horizons
por: Casadevall, Arturo
Publicado: (2018)

Horizon scanning: what next for bovine TB control in England?
por: McCormack, James
Publicado: (2023)

Does normalizing PSA after successful treatment of chronic prostatitis with high PSA value exclude prostatic biopsy?
por: Azab, Sherif, et al.
Publicado: (2012)

Hepatocellular carcinoma, novel therapies on the horizon
por: El Dika, Imane, et al.
Publicado: (2020)

Detection of prostate cancer with complexed PSA and complexed/total PSA ratio - is there any advantage?
por: Strittmatter, F, et al.
Publicado: (2011)

The Relationship between Prostate Biopsy Results and PSA and Free PSA Ratio Changes in Elevated Serum PSA Patients with and without Antibiotherapy
por: Duran, Mesut Berkan, et al.
Publicado: (2020)

Expanding horizons of biosciences by light-control
por: Kataoka, Mikio, et al.
Publicado: (2021)

A Comparative Performance Analysis of Total PSA, Percentage Free PSA, PSA Velocity, and PSA Density versus the Detection of Primary Circulating Prostate Cells in Predicting Initial Prostate Biopsy Findings in Chilean Men
por: Murray, Nigel P., et al.
Publicado: (2014)

Characteristics of α2,3‐sialyl N‐glycosylated PSA as a biomarker for clinically significant prostate cancer in men with elevated PSA level
por: Yoneyama, Tohru, et al.
Publicado: (2021)

Scanning the horizon: emerging hospital-wide technologies and their impact on critical care
por: Suntharalingam, Ganesh, et al.
Publicado: (2005)

Commentary: Hope on the horizon: Heart transplantation with donation after circulatory death
por: Kwon, Jennie H., et al.
Publicado: (2022)

Commentary: Big data in Ophthalmology: A big game changer on horizon
por: Kumar, Nilesh, et al.
Publicado: (2021)

Beyond the horizon: the newly found sinner disturbing mesenchymal stromal niche
por: Zhang, Xi
Publicado: (2022)

Degrading AR-Dependent Cancers: Expanding the Role of PROTACs
por: Michmerhuizen, Anna R., et al.
Publicado: (2020)

Commentary: Vita brevis, ars longa, iudicium difficile
por: Holman, William L., et al.
Publicado: (2021)

Personalization of prostate cancer prevention and therapy: are clinically qualified biomarkers in the horizon?
por: Yap, Timothy A, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_ro1gak24hngnl17l4pss50ujnd